Scentian Bio
Scentian Bio is a New Zealand synthetic biology company that has developed a portable biosensor platform combining synthesized insect olfactory receptors with AI to detect volatile organic compounds in real time, initially serving food and beverage quality control customers with planned expansion into medical diagnostics and environmental monitoring.
- Company typePrivate
- Founded2021
- HeadquartersAuckland, New Zealand
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Scentian Bio does
Scentian Bio is a New Zealand-based synthetic biology company founded in 2021 as a spin-out from Plant & Food Research. The company has developed a proprietary biosensor platform that combines a synthesized library of 52 insect olfactory receptors with nanotechnology and artificial intelligence to detect volatile organic compounds in real time. The technology is grounded in approximately 19–20 years of fundamental research by founder and CTO Dr Andrew Králíček, and achieves sensitivity at the femtomolar level — described by the company as roughly 1,000 times more sensitive than a dog's nose. The platform is delivered through a portable device that returns results in minutes, displacing centralized laboratory testing.
The company's near-term commercial focus is the food and beverage industry, with its first digital biosensor solution scheduled for launch at the end of 2024 and initially targeting essential oils quality control before expanding to other food ingredients. Identified use cases include flavor consistency across seasons and orchards, adulterant and fraud detection, and identification of off-notes, taints, and mal-odours. Beyond food, the company has disclosed a disease detection roadmap targeting tuberculosis and malaria via breath-based volatile biomarkers, supported by a US$1.7 million Bill & Melinda Gates Foundation grant, as well as longer-term optionality in flavor and fragrance, environmental monitoring, and agricultural technology. The go-to-market is direct enterprise field sales targeting large food and beverage manufacturers, with seven food sector pilot customers and pre-market engagement with global food companies as of mid-2024.
Scentian Bio generates revenue through hardware sales of biosensor devices, recurring quality control solutions, and longer-term platform licensing. Pricing is not publicly disclosed and follows a quote-based B2B enterprise model. The company has raised approximately US$7 million across a 2021 NZ$1 million seed round, a 2022 US$1.7 million Gates Foundation grant, 2023 seed rounds (NZ$3.5M / US$2.1M reported across sources) co-led by Finistere Ventures and Toyota Ventures, and a 2024 US$7 million pre-Series A round led by Icehouse Ventures. Key technology partners include Plant & Food Research (exclusive IP licensor) and Cardea Bio (graphene transistor transducer platform). The headcount is 1–10 employees and the company operates from headquarters at 120 Mount Albert Road, Auckland, with a manufacturing facility being set up in Auckland.
Scentian Bio firmographics
Firmographics- Name
- Scentian Bio
- Legal name
- Scentian Bio Limited
- Website
- https://scentianbio.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Scentian Bio is a New Zealand synthetic biology company that has developed a portable biosensor platform combining synthesized insect olfactory receptors with AI to detect volatile organic compounds in real time, initially serving food and beverage quality control customers with planned expansion into medical diagnostics and environmental monitoring.
- Ownership category
- akta.pro rank
Scentian Bio industry classification
Industry- Product category
- Biosensor Technology
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Flavors, Fragrances & Aroma Chemicals (IMAEABAE)
Keywords
Where Scentian Bio is headquartered
LocationHeadquarters
- HQ city
- Auckland
- HQ country
- New Zealand
- HQ region
- Oceania
Offices2 records
Markets served
Scentian Bio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Biosensor Device Sales: Sale of portable biosensor hardware devices for food quality control and other applications. First commercial digital biosensor solution expected to launch at end of 2024, initially focusing on essential oils quality control.
- Quality Control Solutions: Providing real-time chemical sensing solutions for food and beverage customers, including quality control, quality assurance, and detection of taints, mal-odours or residues.
- Disease Detection Diagnostics: Non-invasive, real-time, early detection diagnostic devices for human diseases using volatile biomarkers, targeting tuberculosis and malaria detection.
- Platform Technology Licensing: Licensing of proprietary biosensor platform technology based on insect olfactory receptors for various industry applications including food, flavor, fragrances, and wellness.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Scentian Bio product offering
Product offeringCore offering
Scentian Bio develops and commercializes a portable biosensor platform that combines 52 synthesized insect olfactory receptors with AI signal processing and nanotechnology transducers to detect volatile organic compounds (VOCs) in real time at femtomolar sensitivity. The company's first commercial product targets quality control and quality assurance in the food and beverage industry (initially essential oils), with planned expansion into medical diagnostics (tuberculosis and malaria detection) and environmental monitoring. The platform is licensed from Plant & Food Research and is delivered as hardware devices with embedded proprietary software.
Product overview
Scentian Bio has developed a modular biosensor platform combining synthesized insect olfactory receptors with nanotechnology and AI. The core Real-time Chemical Sensing Biosensor Platform serves as the foundational technology, upon which the company has built specific solutions including a Food & Flavour Quality Control Solution targeting the food and beverage industry, and a Disease Detection Biosensor for medical diagnostics. The platform leverages 52 synthesized insect olfactory receptors and proprietary AI algorithms to interpret complex chemical signatures, delivering real-time insights across food safety, health diagnostics, and environmental monitoring applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Real-time Chemical Sensing Biosensor Platform A portable biosensor device combining 52 synthesized insect olfactory receptors with nanotechnology transducers and proprietary AI signal processing to detect and interpret volatile organic compounds (VOCs) in real time at femtomolar sensitivity. Serves as the foundational technology platform deployed across food quality control, disease diagnostics, and environmental monitoring applications.
- Food & Flavour Quality Control Solution Industry-specific application of the biosensor platform that delivers real-time quality control and quality assurance for food, beverage, flavor, and fragrance ingredients. Detects taints, mal-odours, residues, off-notes, fraud, and adulterants in raw materials and finished products, replacing slow lab testing and subjective human sensory panels for food and beverage manufacturers.
- Disease Detection Biosensor (Tuberculosis and Malaria) Non-invasive diagnostic application of the biosensor platform that uses volatile biomarkers in breath for real-time, early detection of human diseases, with current development focused on tuberculosis and malaria detection. Targeted at healthcare providers and public health agencies, especially in resource-poor settings lacking access to centralized lab testing.
Quantifiable outcome
- 1000x more sensitive than a dog's nose
- +2 more outcomes
Companies that use Scentian Bio
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles4 records
Scentian Bio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
Scentian Bio partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Plant & Food ResearchcoreSpin-out partner from which Scentian Bio licensed its core biosensor technology. Dr Andrew Kralicek spent 19 years at Plant & Food Research developing the insect olfactory receptor technology. The platform technology is exclusively licensed from this New Zealand Crown Research Institute.
- Cardea BiocorePartnership with San Diego-based Cardea Bio, makers of graphene transistor nano chips, to host the receptor technology. Cardea's transistor chips serve as the transducer platform for Scentian Bio's biosensors.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Scentian Bio competitors and assessment
Company assessmentDirect peers
- AerNos: Developer of nano gas sensors for environmental monitoring, health, and food safety applications. Comparable miniaturized gas-sensing platform competing in adjacent VOC detection verticals.
- Aryballe: France/US-based developer of digital olfaction sensors using biochemistry, optics, and AI for F&F QC, automotive, and healthcare. Directly comparable as a digital/biosensor nose targeting food and flavor applications.
- Alpha MOS (now under Microtrace): Long-established electronic nose manufacturer focused on F&B quality control and sensory analysis. Closest legacy incumbent in VOC sensing for food quality, the same vertical Scentian Bio is entering.
- Sensigent: US-based electronic nose/sensor technology provider serving industrial safety, environmental monitoring, and food applications. Comparable as a multi-vertical e-nose competitor with overlapping use cases.
- NanoScent: Israeli startup developing scent-detection technology using nano-sensor arrays and AI for F&B, medical, and security applications. Early-stage peer with similar product archetype and vertical breadth.
Broad incumbents
- 908 Devices: Public US-based maker of mass spectrometry and analytical instruments for chemical and biomolecular analysis. A larger established analytical instrument player whose portable chemical analyzers overlap with Scentian Bio's QC use case in food and safety.
- Smiths Detection: Global leader in threat detection and sensing technologies (chemical, biological, radiological). Comparable as a broad-incumbent in chemical sensing with adjacent environmental and security use cases.
- Sensirion: Swiss manufacturer of high-quality gas and flow sensors used in industrial, medical, and consumer applications. Broad incumbent in miniaturized gas-sensor hardware, an enabling/comparable technology layer to Scentian's biosensor approach.
- ams Osram: Global sensor and lighting solutions provider with gas-sensing product lines for environmental and health applications. Broad incumbent enabling or competing in VOC sensing hardware.
Others
- Cardea Bio: San Diego-based maker of graphene transistor bio-chips that serves as Scentian Bio's transducer partner. Relevant as an adjacent enabling technology platform, not a direct competitor, but a key node in Scentian's stack.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Scentian Bio social profiles
Digital presenceScentian Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Scentian Bio leadership team
Management profileNumber of profiles
Profiles11 records
Scentian Bio funding detail
Funding detailFunding overview
Funding rounds8 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Scentian Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Scentian Bio
What does Scentian Bio do?
Scentian Bio develops and commercializes a portable biosensor platform that combines 52 synthesized insect olfactory receptors with AI signal processing and nanotechnology transducers to detect volatile organic compounds (VOCs) in real time at femtomolar sensitivity. The company's first commercial product targets quality control and quality assurance in the food and beverage industry (initially essential oils), with planned expansion into medical diagnostics (tuberculosis and malaria detection) and environmental monitoring. The platform is licensed from Plant & Food Research and is delivered as hardware devices with embedded proprietary software.
Is Scentian Bio a public or private company?
Scentian Bio is a private company. It is classified as venture growth investor backed and is currently operating.
When was Scentian Bio founded?
Scentian Bio was founded in 2021. It employs 11 to 50 people.
Where is Scentian Bio based?
Scentian Bio is headquartered in Auckland, New Zealand, in the Oceania region.
How does Scentian Bio make money?
Four revenue lines are on record. Biosensor Device Sales are the primary driver. The others are quality Control Solutions, disease Detection Diagnostics and platform Technology Licensing.
Who are Scentian Bio's main competitors?
Direct peers on record are AerNos, Aryballe, Alpha MOS (now under Microtrace), Sensigent and NanoScent. Broad incumbents are 908 Devices, Smiths Detection, Sensirion and ams Osram. Cardea Bio is listed as an others.
Does Scentian Bio have an API?
No public API is recorded for Scentian Bio.
What industry is Scentian Bio in?
Scentian Bio's product category is Biosensor Technology. Its primary akta.pro industry code is IMAEABAE, Flavors, Fragrances & Aroma Chemicals. Its NAICS code is 334516 and its SIC code is 3826.